Literature DB >> 2926479

Evidence that glycine mediates the postsynaptic potentials that inhibit lumbar motoneurons during the atonia of active sleep.

M H Chase1, P J Soja, F R Morales.   

Abstract

Postsynaptic inhibition of somatic motoneurons underlies the atonia of active sleep. This inhibitory control depends, in large measure, on the bombardment of motoneurons during active sleep by a unique class of large-amplitude inhibitory postsynaptic potentials (IPSPs). These potentials are present only during this behavioral state and have therefore been designated as active sleep-specific IPSPs (AS-IPSPs). The present study was concerned with determining the neurotransmitter that mediates these AS-IPSPs. Lumbar motoneurons were recorded intracellularly during quiet and active sleep in intact, undrugged, normally respiring cats. The frequency and waveform parameters of the inhibitory postsynaptic potentials recorded from these motoneurons were examined following the microiontophoretic juxta-cellular administration of strychnine (a glycine receptor antagonist) and picrotoxin and bicuculline (GABA receptor antagonists). Microiontophoretically applied strychnine abolished the AS-IPSPs and a majority of smaller-amplitude IPSPs. Neither picrotoxin nor bicuculline modified the frequency, amplitude, or rising phase of the AS-IPSPs or the smaller-amplitude IPSPs. We conclude that the postsynaptic inhibitory drive that impinges on motoneurons during active sleep is principally mediated by glycine or a glycinergic substance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926479      PMCID: PMC6569981     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

1.  Activation of pontine and medullary motor inhibitory regions reduces discharge in neurons located in the locus coeruleus and the anatomical equivalent of the midbrain locomotor region.

Authors:  B Y Mileykovskiy; L I Kiyashchenko; T Kodama; Y Y Lai; J M Siegel
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

Review 2.  Brainstem mechanisms of paradoxical (REM) sleep generation.

Authors:  Pierre-Hervé Luppi; Olivier Clement; Emilie Sapin; Christelle Peyron; Damien Gervasoni; Lucienne Léger; Patrice Fort
Journal:  Pflugers Arch       Date:  2011-11-15       Impact factor: 3.657

3.  Catecholaminergic A1/C1 neurons contribute to the maintenance of upper airway muscle tone but may not participate in NREM sleep-related depression of these muscles.

Authors:  Irma Rukhadze; Nancy J Carballo; Sathyajit S Bandaru; Atul Malhotra; Patrick M Fuller; Victor B Fenik
Journal:  Respir Physiol Neurobiol       Date:  2017-07-12       Impact factor: 1.931

Review 4.  Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence.

Authors:  Subimal Datta; Robert Ross Maclean
Journal:  Neurosci Biobehav Rev       Date:  2007-03-12       Impact factor: 8.989

5.  Unraveling the mechanisms of REM sleep atonia.

Authors:  Patricia L Brooks; John H Peever
Journal:  Sleep       Date:  2008-11       Impact factor: 5.849

6.  Glycine-mediated postsynaptic inhibition is responsible for REM sleep atonia.

Authors:  Peter J Soja
Journal:  Sleep       Date:  2008-11       Impact factor: 5.849

7.  Are all motoneurons created equal in the eyes of REM sleep and the mechanisms of muscle atonia?

Authors:  Gregory D Funk
Journal:  Sleep       Date:  2008-11       Impact factor: 5.849

8.  Confirmation of the consensus that glycinergic postsynaptic inhibition is responsible for the atonia of REM sleep.

Authors:  Michael H Chase
Journal:  Sleep       Date:  2008-11       Impact factor: 5.849

9.  Adventures and tribulations in the search for the mechanisms of the atonia of REM sleep.

Authors:  Leszek Kubin
Journal:  Sleep       Date:  2008-11       Impact factor: 5.849

10.  State-dependent control of lumbar motoneurons by the hypocretinergic system.

Authors:  Jack Yamuy; Simon J Fung; Mingchu Xi; Michael H Chase
Journal:  Exp Neurol       Date:  2009-12-03       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.